We ship our products discreetly in secure / airtight packaging via XpressPost(1-3 business day shipping) to members
No posts found!
The therapeutic potential of psychedelics has been giving hope to a variety of people struggling with their mental health. Although they’ve been outlawed for decades, they seem to relieve some symptoms both long-term and short-term.
There’s a growing number of well-respected scientists who study psilocybin and it is finally yielding positive results – not only because it might be beneficial to patients but also because it provides insights into how psychedelics reset the brain. If the latest results stand up to closer scrutiny, they will transform the way we understand and treat mental illnesses.
The idea that psychedelics might be used for mental health treatment goes back to the 1950s. Later on, psychedelics ended up becoming a part of the counterculture and by the 1970s, they had been banned in the US, Canada, and Europe. Research then came to a halt.
The Psychedelic Science of Pain
Psychedelics and Health Research Initiative explores new territory in treating pain
In the last few years, new research has demonstrated the powerful potential for classical psychedelics, especially psilocybin (the active compound in “magic mushrooms”), to treat a range of mental health disorders, including depression, anxiety and addiction.